AU2002315814A1 - Medicinal composition for treatment of interstitial cystitis - Google Patents

Medicinal composition for treatment of interstitial cystitis

Info

Publication number: AU2002315814A1
Authority: AU; Australia
Prior art keywords: treatment; medicinal composition; interstitial cystitis; cystitis; interstitial
Prior art date: 2001-07-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002315814A

Other versions

AU2002315814B2 (en

Inventor

Ken Ikeda

Makoto Takeuchi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Astellas Pharma Inc

Original Assignee

Astellas Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-10

Filing date

2002-07-08

Publication date

2003-05-22

2002-07-08 Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc

2002-07-08 Priority claimed from PCT/JP2002/006904 external-priority patent/WO2003006019A1/en

2003-05-22 Publication of AU2002315814A1 publication Critical patent/AU2002315814A1/en

2005-12-22 Assigned to ASTELLAS PHARMA INC. reassignment ASTELLAS PHARMA INC. Request for Assignment Assignors: YAMANOUCHI PHARMACEUTICALS CO., LTD.

2007-05-31 Application granted granted Critical

2007-05-31 Publication of AU2002315814B2 publication Critical patent/AU2002315814B2/en

2022-07-08 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

208000005615 Interstitial Cystitis Diseases 0.000 title 1

AU2002315814A 2001-07-10 2002-07-08 Medicinal composition for treatment of interstitial cystitis Ceased AU2002315814B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2001-209041		2001-07-10
JP2001209041		2001-07-10
PCT/JP2002/006904 WO2003006019A1 (en)	2001-07-10	2002-07-08	Medicinal composition for treatment of interstitial cystitis

Publications (2)

Publication Number	Publication Date
AU2002315814A1 true AU2002315814A1 (en)	2003-05-22
AU2002315814B2 AU2002315814B2 (en)	2007-05-31

Family

ID=19044753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002315814A Ceased AU2002315814B2 (en)	2001-07-10	2002-07-08	Medicinal composition for treatment of interstitial cystitis

Country Status (19)

Country	Link
US (2)	US7335668B2 (en)
EP (1)	EP1405638B1 (en)
JP (1)	JP4174673B2 (en)
KR (1)	KR100874815B1 (en)
CN (1)	CN1270708C (en)
AT (1)	ATE497765T1 (en)
AU (1)	AU2002315814B2 (en)
BR (1)	BR0210873A (en)
CA (1)	CA2449922C (en)
CY (1)	CY1112600T1 (en)
DE (1)	DE60239134D1 (en)
DK (1)	DK1405638T3 (en)
ES (1)	ES2359719T3 (en)
MX (1)	MXPA04000124A (en)
PL (1)	PL208138B1 (en)
PT (1)	PT1405638E (en)
RU (1)	RU2290929C2 (en)
WO (1)	WO2003006019A1 (en)
ZA (1)	ZA200309632B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2558877A1 (en) *	2004-02-09	2005-08-18	Astellas Pharma Inc.	Solifenacin succinate-containing composition
JPWO2005087231A1 (en)	2004-03-16	2008-01-24	アステラス製薬株式会社	Solifenacin-containing composition
US7820690B2 (en) *	2004-03-19	2010-10-26	Solvay Pharmaceuticals Gmbh	Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist
US8039482B2 (en)	2004-03-25	2011-10-18	Astellas Pharma Inc.	Composition of solifenacin or salt thereof for use in solid formulation
CN101601673B (en) *	2004-03-25	2012-07-18	安斯泰来制药株式会社	Composition for solid pharmaceutical preparation of solifenacin or salt thereof
EP1775283A4 (en) *	2004-07-14	2008-12-10	Japan Tobacco Inc	3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor
BRPI0513286A (en)	2004-07-15	2008-05-06	Japan Tobacco Inc	condensed benzamide compounds and subtype (vr1) vanilloid receptor activity inhibitors, their pharmaceutical compositions, commercial package, drug and their uses
TWI356699B (en) *	2004-11-10	2012-01-21	Kissei Pharmaceutical	Agent for treating interstitial cystitis and agent
EP1832288B1 (en) *	2004-12-27	2012-06-20	Astellas Pharma Inc.	Stable granular pharmaceutical composition of solifenacin or its salt
US20090131469A1 (en) *	2005-02-25	2009-05-21	Astellas Pharma Inc.	Pharmaceutical agent comprising solifenacin
JP3701964B1 (en) *	2005-03-08	2005-10-05	アステラス製薬株式会社	Novel salts of quinuclidine derivatives
US7815939B2 (en)	2005-07-20	2010-10-19	Astellas Pharma Inc.	Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
JP4614084B2 (en) *	2005-07-25	2011-01-19	アステラス製薬株式会社	Pharmaceutical composition containing quinuclidine derivative
US7906508B2 (en) *	2005-12-28	2011-03-15	Japan Tobacco Inc.	3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity
CA2632508A1 (en)	2005-12-28	2008-06-05	Japan Tobacco Inc.	3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity
TWI482629B (en) *	2008-07-01	2015-05-01	Tobishi Pharmaceutical Co	A therapeutic agent for lower urinary tract diseases and an improving agent for lower urinary tract symptoms
MD4025C2 (en) *	2009-08-25	2010-10-31	Владимир КАРАУШ	Remedy for treating prostatitis and prostate hyperplasia
EP2818166A1 (en) *	2013-06-26	2014-12-31	Laboratorios del Dr. Esteve S.A.	Use of sigma receptor ligands for the prevention and treatment of pain associated to interstitial cystitis/bladder pain syndrome (IC/BPS)
DE102022104759A1 (en)	2022-02-28	2023-08-31	SCi Kontor GmbH	Co-crystal screening method, in particular for the production of co-crystals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO2005012I1 (en) *	1994-12-28	2005-06-06	Debio Rech Pharma Sa	Triptorelin and pharmaceutically acceptable salts thereof
PT1011695E (en) *	1997-07-15	2006-07-31	Univ Colorado	USING NEUROTOXIN THERAPY FOR TREATMENT OF PROSTATE DISEASES
KR100375003B1 (en) *	1998-11-05	2003-03-06	다이호야쿠힌고교 가부시키가이샤	Therapeutic drug for the treatment of micturition disorders
AU6686700A (en) *	1999-08-23	2001-03-19	H. Lundbeck A/S	Treatment of urinary incontinence

2002
- 2002-07-08 MX MXPA04000124A patent/MXPA04000124A/en active IP Right Grant
- 2002-07-08 DK DK02741446.5T patent/DK1405638T3/en active
- 2002-07-08 US US10/479,798 patent/US7335668B2/en not_active Expired - Lifetime
- 2002-07-08 BR BR0210873-9A patent/BR0210873A/en not_active IP Right Cessation
- 2002-07-08 RU RU2004103746/15A patent/RU2290929C2/en not_active IP Right Cessation
- 2002-07-08 PT PT02741446T patent/PT1405638E/en unknown
- 2002-07-08 JP JP2003511825A patent/JP4174673B2/en not_active Expired - Fee Related
- 2002-07-08 KR KR1020047000284A patent/KR100874815B1/en not_active IP Right Cessation
- 2002-07-08 DE DE60239134T patent/DE60239134D1/en not_active Expired - Lifetime
- 2002-07-08 AU AU2002315814A patent/AU2002315814B2/en not_active Ceased
- 2002-07-08 CN CNB028140303A patent/CN1270708C/en not_active Expired - Fee Related
- 2002-07-08 PL PL366731A patent/PL208138B1/en not_active IP Right Cessation
- 2002-07-08 ES ES02741446T patent/ES2359719T3/en not_active Expired - Lifetime
- 2002-07-08 AT AT02741446T patent/ATE497765T1/en active
- 2002-07-08 EP EP02741446A patent/EP1405638B1/en not_active Expired - Lifetime
- 2002-07-08 WO PCT/JP2002/006904 patent/WO2003006019A1/en active IP Right Grant
- 2002-07-08 CA CA002449922A patent/CA2449922C/en not_active Expired - Fee Related
- 2002-07-08 ZA ZA200309632A patent/ZA200309632B/en unknown
2008
- 2008-01-03 US US12/003,908 patent/US20090105298A1/en not_active Abandoned
2011
- 2011-03-11 CY CY20111100272T patent/CY1112600T1/en unknown

Similar Documents

Publication	Publication Date	Title
AU2002315814A1 (en)	2003-05-22	Medicinal composition for treatment of interstitial cystitis
AU2002329990A1 (en)	2003-03-24	Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
AU2002257936A1 (en)	2002-12-03	Methods of well treatment
AUPR638101A0 (en)	2001-08-09	Composition and method for treatment of disease
AU2002252456A1 (en)	2002-10-08	Combination treatment of pancreatic cancer
AU2002342613A1 (en)	2002-11-25	Treatment for wounds
AU2002328952A1 (en)	2003-02-24	Irinotecan for treatment of cancer
AU2003300791A1 (en)	2004-07-09	Combination therapy for the treatment of pain
AU2001233081A1 (en)	2001-08-07	Composition for treatment of stress
ZA200707934B (en)	2009-03-25	Thereapeutic formulations for the treatment of beta-amyloid related diseases
AU2000276362A1 (en)	2002-01-21	Composition for the treatment of diabetes
AU2002352533A1 (en)	2003-03-03	Methods and compositions for treatment of gastric diseases
AU2002240359A1 (en)	2002-08-28	Pharmaceutical composition for the treatment of alopecia
AU2003903387A0 (en)	2003-07-17	Combination therapy for treatment of neoplasia
AU2002330095A1 (en)	2003-04-07	Flavonoids for treatment of diabetes
AU2002322481A1 (en)	2003-02-24	Use of r-nsaid compounds for anti-hiv treatment
AU2003237969A1 (en)	2004-01-06	Pharmaceutical composition comprising calcium channel blockers for the treatment of pain
AU2003210659A1 (en)	2003-09-02	Combination therapy for treatment of hiv infection
AU2002322082A1 (en)	2003-01-02	Pharmaceutical composition for the treatment of viral infection
AU2002327440A1 (en)	2003-03-10	Treatment of type i diabetes
AU2003264954A1 (en)	2004-04-19	Pharmaceutical composition for prevention and treatment of kidney diseases
GB0212790D0 (en)	2002-07-10	Medicament for the treatment of diabetes
AUPR520701A0 (en)	2001-06-14	Herbal composition for the treatment of drug addiction
AUPR637001A0 (en)	2001-08-09	Pharmaceutical composition for the treatment of skin conditions
AU2002341485A1 (en)	2003-05-12	Treatment of polyaluminium compounds